Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Institute of Health"


12 mentions found


According to the group's projections, cases in China would peak around April 1, when deaths would reach 322,000. About a third of China's population will have been infected by then, IHME Director Christopher Murray said. China's national health authority has not reported any official COVID deaths since the lifting of COVID restrictions. Based on China's population of 1.41 billion, and without measures such as a mass vaccination booster campaign, that amounts to 964,400 deaths. China's National Health Commission said on Friday it was ramping up vaccinations and building stocks of ventilators and essential drugs.
2023 could see over 1 million COVID-19 deaths in China, per Reuters' analysis of a new report. The report predicts that the COVID-19 death toll in China could reach over 300,000 by April 2023. The IHME has suggested that the virus would peak at the start of April 2023, when they believe the country's COVID-19 deaths will soar to 322,000. It's just that that's the biggest concentration right now for that at-risk population," Murray said of the over-80 population. China has refused to use western vaccines in its fight against COVID-19, instead relying on its homegrown inoculations.
According to the group's projections, cases in China would peak around April 1, when deaths would reach 322,000. About a third of China's population will have been infected by then, IHME Director Christopher Murray said. China's national health authority has not reported any official Covid deaths since the lifting of Covid restrictions. China's zero-Covid policy may have been effective at keeping earlier variants of the virus at bay, but the high transmissibility of Omicron variants made it impossible to sustain, he said. Based on China's population of 1.41 billion, and without measures such as a mass vaccination booster campaign, that amounts to 964,400 deaths.
[1/5] People wait to purchase medicine at a pharmacy, amid the coronavirus disease (COVID-19) outbreak, in Beijing, China December 16, 2022. REUTERS/Xiaoyu YinBEIJING/SHANGHAI, Dec 17 (Reuters) - Funeral homes across China's COVID-hit capital Beijing, a city of 22 million, scrambled on Saturday to keep up with calls for funeral and cremation services as workers and drivers testing positive for the novel coronavirus called in sick. In Beijing, which has yet to report any COVID deaths since the policies changed on Dec. 7, sick workers have hit the staffing of services from restaurants and courier firms to its roughly one dozen funeral parlours. "We've fewer cars and workers now," a staffer at Miyun Funeral Home told Reuters, adding that there was a mounting backlog of demand for cremation services. China's health authority last reported COVID deaths on Dec. 3, in Shandong and Sichuan provinces.
As the supply of Paxlovid has grown, efforts have been made to improve timely, equitable access to the treatment. Transportation is one significant barrier to health care access for many people, experts say, but creating equitable outcomes will involve a much more comprehensive approach. The initiative is meant to increase access to Covid-19 treatment, particularly for those in socially vulnerable or medically underserved communities. “It’s a combination of things that prevent access to care,” said Werner, whose research has focused on health equity. And those may be the ones that I think would be ripe for this kind of home-based delivery system,” Werner said.
Dr. Anthony Fauci, the top infectious disease expert in the U.S., criticized China's Covid lockdowns as "draconian" and said the Beijing government should focus on vaccinating the elderly. Fauci said lockdowns are only justifiable as a temporary measure to serve a larger public health goal that will make society safer when it reopens. But China's strict Covid controls don't seem to have any endgame, he said. Rare protests broke out across China over the weekend against Covid lockdowns and strict quarantine procedures. "The efficacy of the China-made vaccines are not at the level of the vaccines that have been used in the United States, particularly the mRNA vaccines of Moderna and Pfizer," Fauci said.
Number of steps: Aim for 9,800 - 10,000 a dayFor every 2,000 steps, risk of heart disease, cancer and premature death decreases by 10%, peaking at 10,000 steps each day, the research shows. Additionally, a little under 10,000 steps a day (9,800) can drop risk of dementia by 50%. And "adults who took 8,000 or more steps a day had a reduced risk of death over the following decade than those who only walked 4,000 steps a day," according to the National Institute of Health. At 112 steps per minute, individuals were able to lower their reduction risk of the condition by 38%. The individuals included in the study did not have cardiovascular disease, cancer or dementia when the research first began.
Fauci said he had a "bad feeling" ahead of Trump's presser where he spoke of COVID-19 and disinfectants. "And as soon as I heard it, I said, holy [expletive], this is going to go bad," Fauci told ABC News. For much of 2020, Fauci was a fixture on the televised White House COVID-19 briefings. "I didn't want to go up on there with this because I had a bad feeling about when Homeland Security brought this guy in, he briefed the people in the Situation Room beforehand. Fauci was at one time a fixture of the White House press briefings for much of 2020.
Relmada's depression drug fails late-stage trial; shares crash
  + stars: | 2022-10-13 | by ( ) www.reuters.com   time to read: +1 min
Oct 13 (Reuters) - Relmada Therapeutics Inc's (RLMD.O) experimental treatment for major depressive disorder failed a keenly anticipated late-stage study, sending the drug developer's shares plunging 85% in premarket trading. The drug, REL-1017, which is also the company's lead experimental therapy in development, did not show statistically significant improvement in symptoms of depression when compared to a placebo. Relmada said it would keep studying REL-1017 as an adjunctive or in combination with other depression drugs in its ongoing late-stage studies. Register now for FREE unlimited access to Reuters.com RegisterInvestors are likely to lose confidence in the two adjunctive trials, Mizuho Securities analyst Uy Ear said. Register now for FREE unlimited access to Reuters.com RegisterReporting by Khushi Mandowara in Bengaluru; Editing by Sriraj KalluvilaOur Standards: The Thomson Reuters Trust Principles.
CNN —People who got the Covid-19 vaccine reported slightly longer menstrual cycles, but the change was temporary, according to a new study published Tuesday in the journal BMJ Medicine. “We found no differences in menses length in any group of vaccinated individuals, compared with the unvaccinated cohort,” the study says. The changes to the length of the cycle didn’t remain in the cycle after vaccination, the authors said – apart from in the group that received two doses in one cycle. For the vaccinated cohort, they looked at three prevaccine cycles and at least the first Covid-19 vaccine dose cycle. Nearly two-thirds of the 15,000 vaccinated participants had received the Pfizer/BioNTech vaccine, although participants had also received the Johnson & Johnson, Moderna and Oxford-AstraZeneca vaccines among others.
A displaced woman holds her ailing boy, while taking refuge in a camp, following rains and floods during the monsoon season in Sehwan, Pakistan, September 16, 2022. read moreRegister now for FREE unlimited access to Reuters.com RegisterThe provincial government said in a report issued on Tuesday that nine people died of gastroenteritis, acute diarrhoea and suspected malaria on Monday. The report said over 72,000 patients were treated on Monday at makeshift or mobile hospitals set up in flood-hit regions. Malaria and diarrhoea are out of control, he said. read moreRegister now for FREE unlimited access to Reuters.com RegisterWriting by Asif Shahzad; Editing by Raju GopalakrishnanOur Standards: The Thomson Reuters Trust Principles.
Un aparat pentru respiraţie care poate fi de mare ajutor, în afara secţiilor de terapie intensivă (ATI), pacienţilor diagnosticaţi cu COVID-19, a fost creat în circa o săptămână de ingineri britanici şi germani. Dispozitivul a fost creat de specialişti de la University College London (UCL), UCLH din Londra şi Mercedes Formula One. China şi Italia le-au folosit pentru a ajuta pacienţii COVID-19 să poată respira. Primele rapoarte din Lombardia (Italia) sugerează că aproximativ 50% dintre pacienţii care au folosit CPAP nu au mai avut nevoie de ventilaţie mecanică invazivă. 40 de astfel de măşti CPAP au fost livrate către ULCH şi alte trei spitale londoneze.
Persons: Rebecca Shipley, Mervyn Singer, Duncan Young, Profesorul Mervyn Singer Organizations: BBC, University College London, Mercedes Formula One, UCL, Healthcare, Universităţii Locations: Londra, China, Italia, Lombardia, Universităţii Oxford
Total: 12